Financial News · Live Terminal

Page 374 of 3481

Unimicron Technology Logs NT$18.2 Billion in H1 Profit

Unimicron Technology (TPE:3037) posted a profit attributable to owners of NT$18.2 billion in the first half of 2026.Basic earnings stood at NT$11.70 per share.Operating revenue accumulated amounted to NT$80.3 billion, according to a Tuesday Taiwan Exchange filing.The printed circuit board manufacturer did not provide comparative year-ago figures.

TPE:3037

Asia12d ago

President Chain Store Leases Property Worth NT$18 Million

President Chain Store (TPE:2912) acquired the right to use a property in Taichung, Taiwan, for NT$18.3 million, for operational needs.The right-of-use asset covers about 35 ping of space, and was purchased from related-party, President Drugstore Business, according to a Tuesday Taiwan Exchange filing.The lease runs from August 2026 to June 2034. The transaction remains subject to approval by the board on July 29, it said.

TPE:2912

Research12d ago

UBS Initiates TransMedics Group at Neutral With $80 Price Target

TransMedics Group (TMDX) has an average rating of overweight and mean price target of $112.89, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$TMDX

Research12d ago

UBS Downgrades Crinetics Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $85 From $55

Crinetics Pharmaceuticals (CRNX) has an average rating of hold and mean price target of $85.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$CRNX

Research12d ago

Morgan Stanley Downgrades Laureate Education to Underweight From Equalweight, Adjusts PT to $34.50 From $36.50

Laureate Education (LAUR) has an average rating of overweight and mean price target of $40.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$LAUR

Equities12d ago

HF Sinclair Q2 Adjusted Earnings, Revenue Rise; Dividend Raised

HF Sinclair (DINO) reported Q2 adjusted earnings Tuesday of $5.31 per share, up from $1.70 a year earlier.Analysts surveyed by FactSet expected $4.49.Revenue for the quarter ended June 30 was $10.39 billion, up from $6.78 billion a year earlier.Analysts polled by FactSet expected $8.68 billion.The company also said it has raised its quarterly dividend by 5% to $0.525 a share, payable Sept. 2 to holders of record Aug. 11.Shares of the company were up 5% in recent Tuesday premarket activity.

$DINO

International12d ago

India's Industrial Output Growth Accelerates to 7.3% in June

India's industrial production growth expanded to 7.3% year over year in June from the revised 5% in May, according to quick estimates from the Ministry of Statistics and Programme Implementation released on Tuesday.The reading beats the consensus forecast of 5.6% growth tracked by Investing.com.

^BSENifty 50

Mining & Metals12d ago

Kelso Technologies Swings to Q2 Net Loss YoY

Kelso Technologies (KLS.TO) reported second-quarter net loss of $326,972, or a loss of $0.01 per share, swinging from a net income of $72,125, or $0.00 per share, in the year-ago quarter.Revenues were $2.2 million, down from $2.6 million in the year-ago quarter.

$KLS.TO

Research12d ago

UBS Initiates Bausch + Lomb at Buy With CA$29.64 Price Target

Bausch + Lomb (BLCO) has an average rating of overweight and mean price target of CA$25.55, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$BLCO

Asia12d ago

Nitto Denko Profit Rises 8% in Fiscal Q1

Nitto Denko (TYO:6988) posted an 8.2% year-over-year increase in net profit attributable to owners of the parent to 33.87 billion yen for the three months ended June 30 from 31.30 billion yen.The adhesive manufacturer's basic earnings per share increased to 50.75 yen from 45.68 yen a year ago, according to a Tokyo bourse filing on Tuesday.Revenue jumped 10.3% to 271.67 billion yen during the period from 246.2 billion yen in the year-ago period.For the fiscal year ending March 31, 2027, the company expects attributable profit of 142 billion yen, basic EPS of 212.75 yen, and revenue of 1.11 trillion yen.Nitto Denko plans to pay a second-quarter dividend of 32 yen for the current fiscal year.

TYO:6988

Research12d ago

UBS Initiates Alphatec Holdings at Buy With $15 Price Target

Alphatec Holdings (ATEC) has an average rating of buy and mean price target of $15.92, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$ATEC

Research12d ago

Wells Fargo Downgrades Levi Strauss & Co. to Equalweight From Overweight, Price Target is $25

Levi Strauss & Co. (LEVI) has an average rating of overweight and mean price target of $28.20, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$LEVI

Research12d ago

Stephens Downgrades Eastern Bankshares to Equalweight From Overweight, Price Target is $24

Eastern Bankshares (EBC) has an average rating of buy and mean price target of $25.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$EBC

Research12d ago

Barclays Downgrades Progyny to Equalweight From Overweight, Adjusts Price Target to $34 From $27

Progyny (PGNY) has an average rating of buy and mean price target of $34, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$PGNY

Research12d ago

TD Cowen Downgrades RXO to Sell From Hold, Adjusts Price Target to $19 From $24

RXO (RXO) has an average rating of hold and mean price target of $24.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$RXO

Asia12d ago

Hyundai Rotem Wins KRW358.5 Billion Taiwan Railway Line E&M Supply Project

Hyundai Rotem (KRX:064350) received a notice of award from the Taoyuan City Government for the Taoyuan brownline electrical and mechanical (E&M) supply project in Taiwan, with the company's share amounting to 358.5 billion won.The railway rolling stock manufacturer said the project will be carried out in consortium with ST Engineering Urban Solutions.The company plans to file a separate disclosure for the single sales and supply contract upon final signing, according to a bourse filing on Tuesday.

KRX:064350

Equities12d ago

Earnings Flash (XPRO) Expro Posts Q2 Adjusted EPS $0.15, vs. FactSet Est of $0.17

$XPRO

Asia12d ago

WPG to Exit Shenzhen CECport Technologies Stake for At Least 108 Million Yuan

WPG (TPE:3702) unit WPG China approved the disposal of up to 7.2 million shares in Shenzhen CECport Technologies for at least 108.1 million yuan.The shares will be sold at a price of at least NT$90 per share, according to a Tuesday Taiwan Exchange filing.The company said the sale will enhance capital utilization efficiency and profitability.Following the disposal, WPG China will no longer hold any shares in Shenzhen CECport Technologies.

TPE:3702

Equities12d ago

Earnings Flash (XPRO) Expro Posts Q2 Revenue $393.2M, vs. FactSet Est of $387.4M

$XPRO

Research12d ago

Wedbush Initiates Benitec Biopharma at Outperform With $16 Price Target

Benitec Biopharma (BNTC) has an average rating of buy and mean price target of $25.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$BNTC

Showing 7461-7480 of 69608